|

B7-H3-CAR T cells Clinical Trials

3 actively recruiting trials across 1 location

Also known as: CAR T- cell infusion

Pipeline

Phase 1: 3

Top Sponsors

  • St. Jude Children's Research Hospital3

Indications

  • Cancer3
  • Ewing Sarcoma2
  • Germ Cell Cancer1
  • Adrenocortical Cancer1
  • Malignant Peripheral Nerve Sheath Tumors1

Memphis, Tennessee3 trials

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

St. Jude Children's Research Hospital

Phase 1
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas

St. Jude Children's Research Hospital

Phase 1
Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors

St. Jude Children's Research Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.